Therapeutic advances in respiratory disease
-
Ther Adv Respir Dis · Jan 2020
Randomized Controlled TrialHigh-flow nasal oxygen reduces endotracheal intubation: a randomized clinical trial.
The benefits of high-flow nasal cannula (HFNC) as primary intervention in patients with acute hypoxemic respiratory failure (AHRF) are still a matter in debate. Our objective was to compare HFNC therapy versus conventional oxygen therapy (COT) in the prevention of endotracheal intubation in this group of patients. ⋯ EUDRA CT number: 2012-001671-36The reviews of this paper are available via the supplemental material section.